TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $449,000 | +189.7% | 5,968 | +3.5% | 0.00% | +300.0% |
| Q1 2022 | $155,000 | -73.8% | 5,765 | -53.5% | 0.00% | -50.0% |
| Q4 2021 | $592,000 | +42.3% | 12,394 | +98.0% | 0.00% | -50.0% |
| Q3 2021 | $416,000 | -20.5% | 6,261 | -6.6% | 0.00% | 0.0% |
| Q2 2021 | $523,000 | +6.7% | 6,705 | +29.5% | 0.00% | -77.8% |
| Q1 2021 | $490,000 | -28.7% | 5,178 | -8.2% | 0.02% | -30.8% |
| Q4 2020 | $687,000 | +53.7% | 5,638 | +10.2% | 0.03% | +36.8% |
| Q3 2020 | $447,000 | +60.2% | 5,115 | +18.5% | 0.02% | +46.2% |
| Q2 2020 | $279,000 | +28.0% | 4,315 | -11.5% | 0.01% | +160.0% |
| Q1 2020 | $218,000 | -29.4% | 4,877 | -1.8% | 0.01% | -16.7% |
| Q4 2019 | $309,000 | – | 4,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |